
MODI PRIX GALIEN INDIA
The world’s preeminent accolade for life science research and innovation was back at the Taj Palace in New Delhi for its exciting second edition this past March 20th.
The event attracted a fantastic turnout to celebrate India’s ever growing contribution to improving the human condition. Emceed by actress Mandira Bedi, the Awards were conferred by Mr. Jadhav Prataprao Ganpatrao, Union Minister of State for Health and Family Welfare, Government of India, in the presence of Satish Kumar Modi and a prestigious line of dignitaries, among them the esteemed Modi Prix Galien India committee.
India is a key player in the production of medicines both in sheer volume and in value worldwide and is the global leader in the production of generic drugs and vaccines ensuring accessibility to treatment to the underprivileged. Many exciting treatments and technologies are being developed in India today with tremendous potential to treat and cure disease on a global scale.
Saatich Kumar Modi stressed the social imperative and commitment to progressive society… “As we celebrate these achievements, we must also recognize the importance of sustainability and accessibility in healthcare innovation. It is our collective responsibility to ensure that these advancements benefit all segments of society.”
“We are excited to continue the Prix Galien legacy by honoring another extraordinary group of winners who exemplify the skill, dedication, and innovation that is essential to the life sciences industry,” said Bruno Cohen, Chairman of The Galien Foundation.
Best Biotech & Pharma Product
Best Academic / Public Sector
Best Medical Technology
Best Startup / Digital Health Solution
Best Biotech & Pharmaceutical Product laureate: Biological E. for Pneubevax 14
Panel "Prioritizing Obesity Care in India"
(l to r): Rhythma KAUL (Moderator), Seema CHHABRA, Dr Rajendra Pratap GUPTA, Dr Chandrakant LAHARIYA, Dr Ratna DEVI
The Prix Galien India Awards committee include 14 esteemed leaders in the life sciences in India. The committee is a neutral body and follows the Prix Galien India Charter in selecting the best of the best in biopharmaceutical research and development. The selection committee will be supported by two sub-comittees that will short list finalists to the competition.
“As we move forward, it is crucial that we continue to foster an ecosystem that encourages innovation and collaboration. The future of healthcare depends on our ability to work together towards transformative solutions,” said Dr. Renu Swarup, Modi Prix Galien India Committee Chair.

COMMITTEE CHAIR:
Dr Renu Swarup, Former Secretary to the Government of India, Department of Biotechnology, Ministry of Science & Technology, New Delhi, India

In memory of Prof Manju Sharma, Inaugural Modi Prix Galien India Committee Chair; Former Secretary to the Govt. of India, Department of Biotechnology. Chair New Initiative, NASI, Allahabad
We are deeply saddened by the passing of our beloved Professor Manju Sharma this past October 31, 2024. Pr. Sharma was a truly wonderful and brilliant leader. The global Galien Foundation community will deeply miss her.
JURY MEMBERS:
Dr Alok Dhawan, Centre for Biomedical Research, Lucknow
Shri Anil Khanna, Sr. Vice President, GM Modi Science Foundation, New Delhi; Honorary Member for Ministry of Food & processing
Pr Paramjit Khurana, Member Secretary
Dr Indranil Manna, President, Indian National Academy of Engineering
Dr Narinder Kr. Mehra, Vice-President - International Affairs, Indian National Science Academy
Dr Debasisa Mohanty, Director, National Institute of Immunology, Department of Biotechnology, Government of India
Pr Ashwani Nangia, Department of Chemistry, University of Hyderabad
Dr Himanshu Pathak, President, National Academy of Agriculture Sciences (NAAS)
Dr Ram Gopal Rao, Vice Chancellor for the Birla Institute of Technology & Science (BITS) Pilani
Dr Shiv Kumar Sarin, President, National Academy of Medical Sciences
Pr Anurag Sharma, Emeritus Professor of Optics and Photonics and Physics at IIT Delhi – Member Secretary
Dr Sanjay Singh, Chief Executive Officer, Gennova Biopharmaceuticals Ltd., Pune
Dr Rohit Srivastava, IIT- Mumbai
Dr Umesh Waghmare, President, Indian Academy of Sciences, Bangalore
Sub-committee in the categories Best Biotechnology Product and Best Product for Orphan/Rare Disease
Pr Sudha Bhattacharya, INSA Senior Scientist at Ashoka University, Sonipat; Fellow of Indian Academy of Sciences (Bengaluru), Indian National Science Academy (New Delhi), and National Academy of Sciences (Allahabad)
Pr Alok Dhawan, Director, Centre of BioMedical Research, Lucknow
Pr Paramjit Khurana, South Campus, University of Delhi – Convenor
Pr Bhaskar Naryan, Director CSIR-Indian Institute of Toxicology Research
Dr Shashi Bala Singh, Director, NIPER, Hyderabad
Pr Nikhil Tandon, Professor and Chair of the Department of Endocrinology and Metabolism at the All India Institute of Medical Sciences (New Delhi)
Pr Sudhanshu Vrati, Founder Dean of the Translational Health Science and Technology Institute Regional Centre for Biotechnology; Professor at the Regional Centre for Biotechnology; Fellow of the Indian National Science Academy, the National Academy of Sciences, India, and the Indian Academy of Science (Faridabad)
Sub-committee in the categories Best Medical Technology (including diagnostics tools), Best StartUp, Best Digital Health Solution and Best Incubator-Accelerator
Pr Madhu Dikshit, CDRI, Lucknow
Pr Vijayalakshmi Ravindranath, Fellow of all the 3 science academies in India, namely Indian National Science Academy, Indian Academy of Sciences, National Academy of Sciences, India; Fellow of the National Academy of Medical Sciences, Indian Academy of Neurosciences and Third World Academy of Sciences, Bangalore
Dr Jitendra Sharma, Managing Director & Founder CEO of Andhra Pradesh MedTech Zone; Founder Executive Director of Kalam Institute of Health Technology; Adjunct lecturer at University of Adelaide, Australia; Chairman of Indian Biomedical Skill Council and a Distinguished Senior Fellow at Niti Aayog, Govt. of India. Member of Strategic Advisory Group of Experts constituted by World Health Organization Headquarters, Geneva for Medical Devices; AMTZ Campus, Visakhapatnam
Dr Sanjeev Sinha, Head of Department of Medicine, AIIMS
Dr Rohit Srivastava, Himanshu Patel Chair Professor in the Department of BSBE, IIT Bombay
Dr Mrutyunjay Suar, Director General of R&D and Innovation at KIIT University, Bhubaneswar and CEO of KIIT Technology Business Incubator; Chairman of Bhubaneswar City Knowledge Innovation Cluster Foundation
Dr K.R. Suresh Nair, Chief Technology Advisor to Foundation for Innovation and Social Entrepreneurship, an initiative of Tata Trust
Dr Premnath Venugopalan, Head of NCL Innovations at CSIR-NCL and Founder Director of Venture Center (National award winning inventive enterprises and deep tech incubator); Chemical engineer and an alumnus of MIT in the US, IIT-Bombay (Pune)
Submission is a simple, easy process. A quick fact sheet and explanatory video of the submission process is available on demand.

Highlights from the first edition
Message from the World Economic Forum

The First edition of the Modi Prix Galien India Awards and Forum was presented by the Gujar Mal Modi Science Foundation and its President Satish Kumar Modi.
India’s Minister of Health and Family Welfare bestowed the first Modi Prix Galien Prizes, affirming the government’s strategic focus and keen emphasis on the burgeoning life science sector, writes Former DBT Secretary Dr. Manju Sharma. Read about it in CNBC.

As early as the sixth century BC, Sushruta, recognized as the “father of surgery” in ancient India, introduced pioneering operations and healing techniques.
He authored Sushruta-samhita, the first important treatise on surgery in the country providing a crucial source of information on matters of surgery, toxicology, pharmacology and pediatrics.
With its long and rich history, the India of today has the academic and scientific infrastructure, the R&D and technology transfer frameworks, the entrepreneurship and the funding to predict double digit growth rates in our current decade. It is no wonder that the world is looking at India with anticipation for new breakthroughs in health.
Prix Galien salutes the nation that has forged a formidable growth strategy in the life science sector since 1970, the year Prix Galien was founded, to become the “World’s Pharmacy” as it is often referred to today. India’s thriving life science sector represents the highest number of FDA approved production facilities outside the US and the country only continues to grow.
The Prix Galien India will be fundamental in:
- Recognizing and promoting excellence and through recognition, while enhancing and encouraging a cycle of scientific research excellence and innovation.
- Fostering a culture of innovation which values creative thinking, risk taking and the development of solutions that address societal challenges and contribute to economic growth.
- Showcasing India’s scientific excellence and potential on the international stage.
We look forward to inducting India’s distinguished innovators to the Galien Foundation Hall of Fame in 2025. The winners will join an illustrious list of innovations benefitting human health since the prize’s inception in France in 1970. It is with pride that the Galien Foundation chronicles and honors the winning teams and encourages individuals having working on breakthrough products, devices and solution to become Foundation members and thus perpetuate the importance of their innovation to the advancement of human health.

“I welcome you to the annual Prix Galien awards for innovative excellence in biomedical products and health technologies. The awards are among the highest honors in science and commerce.”
- Jimmy Carter, US President

“The Prix Galien is a welcome initiative to stimulate creative research and promote excellence.”
- Barack Obama, President of the United States – 2008

“The Prix Galien is the right event, on the right issue at the right time. I thank the Galien Foundation for bringing us together and for recognizing that a healthier world is a safer world and a more just world.”